Psychometric properties of the self-report version of the Quick inventory of depressive symptoms (QIDS-SR16) questionnaire in patients with schizophrenia

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Lako, Irene M ^a   Wigman, Johanna T W ^b,c   Klaassen, Rianne M C ^d   Slooff, Cees J ^e   Taxis, Katja ^a   Bartels Velthuis, Agna A ^b   Bruggeman, Richard ^b   Wiersma, Durk ^b   Cahn, Wiepke ^f   Kahn, René S ^f   de Haan, Lieuwe ^g   Meijer, Carin J ^g   Myin Germeys, Inez ^c   van Os, Jim ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Mental Health Institution Rivierduinen   (Netherlands)

^e Centre for Intellectual Disability and Mental Health Care GGZ Drenthe   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; ARTICLE; BARNES AKATHISIA SCALE; CALGARY DEPRESSION SCALE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DEPRESSION INVENTORY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EMOTIONAL STRESS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MENTAL PATIENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; NETHERLANDS; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOMETRY; PSYCHOSIS; QUICK INVENTORY OF DEPRESSIVE SYMPTOMS; SCHIZOPHRENIA; SELF REPORT; ADOLESCENT; EVALUATION STUDY; MIDDLE AGED; PERSONALITY TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT; YOUNG ADULT;

EID: 84907970431     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0247-2     Document Type: Article

References (43)

1. Siris SG, Bench C: Depression and schizophrenia. In Schizophrenia. 2nd edition. Edited by Hirsch SR, Weinberger D. Oxford, UK: Blackwell; 2003:140-167.
2. Buckley PF, Miller BJ, Lehrer DS, Castle DJ: Psychiatric comorbidities and schizophrenia. Schizophr Bull 2008, 35(2):383-402.
3. Leff J: Depressive symptoms in the course of schizophrenia. In Depression in Schizophrenia. Edited by DeLisi LE. Washington, DC: American Psychiatric Press; 1990:3-23.
4. Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ: The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007, 90(1-3):186-197.
5. Tollefson GD, Andersen SW, Tran PV: The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biol Psychiatry 1999, 46(3):365-373.
6. Lako IM, Taxis K, Bruggeman R, Knegtering H, Burger H, Wiersma D, Slooff CJ: The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. Eur Psychiatry 2012, 27(4):240-244.
7. Schennach-Wolff R, Obermeier M, Seemuller F, Jager M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Maier W, Lemke MR, Ruther E, Klingberg S, Gastpar M, Moller HJ, Riedel M: Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale. Acta Psychiatr Scand 2011, 123(3):228-238.
8. Norman RM, Malla AK, Cortese L, Diaz F: Aspects of dysphoria and symptoms of schizophrenia. Psychol Med 1998, 28(6):1433-1441.
9. Bressan RA, Chaves AC, Pilowsky LS, Shirakawa I, Mari JJ: Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Res 2003, 117(1):47-56.
10. Addington D, Addington J, Matickatyndale E: Assessing depression in schizophrenia-the Calgary depression scale. Br J Psychiatry 1993, 163:39-44.
11. Lindenmayer JP, Kay SR, Plutchik R: Multivantaged assessment of depression in schizophrenia. Psychiatry Res 1992, 42(3):199-207.
12. Moller HJ: Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 2009, 10(1):6-26.
13. Lako IM, Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, Taxis K: A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. J Affect Disord 2012, 140(1):38-47.
14. Beck AT, Steer RA, Ball R, Ranieri W: Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996, 67(3):588-597.
15. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54(5):573-583.
16. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004, 34(1):73-82.
17. Rush AJ, Carmody TJ, Ibrahim HM, Trivedi MH, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM: Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv 2006, 57(6):829-837.
18. Bernstein IH, Wendt B, Nasr SJ, Rush AJ: Screening for major depression in private practice. J Psychiatr Pract 2009, 15(2):87-94.
19. Bernstein IH, Rush AJ, Stegman D, Macleod L, Witte B, Trivedi MH: A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an adult outpatient clinical sample. CNS Spectr 2010, 15(7):458-468.
20. Korver N, Quee PJ, Boos HB, Simons CJ, De Haan L, GROUP Investigators: Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 2012, 21(3):205-221.
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV: Washington. Washington, D.C: American Psychiatric Association; 1994.
22. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
23. Guy W: ECDEU Assessment Manual for Psychopharmacology (DHHS Publ No ADM 91-338). Washington, DC: Rockvill: MD, U.S. Department of Health, Education, and Welfare; 1976.
24. Barnes TR: A rating scale for drug-induced akathisia. Br J Psychiatry 1989, 154:672-676.
25. Bressan RA, Chaves AC, Shirakawa I, De Mari J: Validity study of the Brazilian version of the Calgary depression scale for schizophrenia. Schizophr Res 1998, 32(1):41-49.
26. Bentsen H, Munkvold OG, Notland TH, Boye B, Bjoerge H, Lersbryggen AB, Oskarsson K, Berg-Larsen R, Malt UF: The interrater reliability of the Positive and Negative Syndrome Scale (PANSS). Int J Methods Psychiatr Res 1996, 6:227-235.
27. Van der Gaag M, Hoffman T, Remijsen M, Hijman R, De Haan L, Van Meijel B, Van Harten PN, Valmaggia L, De Hert M, Cuijpers A, Wiersma D: The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res 2006, 85(1-3):280-287.
28. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55(3):181-184.
29. Gadermann AM, Guhn M, Zumbo D: Estimating ordinal reliability for Likert-type and ordinal item response data: a conceptual, empirical, and practical guide. Practical Assess Res Eval 2012, 17(3):1-13.
30. Revelle W: An overview of the psych package. 2011, Retrieved from https://sapa-project.org/r/.
31. Bernaards CA, Jennrich RI: Gradient projection algorithms and software for arbitrary rotation criteria in factor analysis. Educ Psychol Meas 2005, 65:676-696.
32. Streiner DL: Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 2003, 80(1):99-103.
33. Clark LA, Watson D: Constructing validity: basic issues in objective scale development. Psychol Assess 1995, 7:309-319.
34. O'Connor BP: SPSS and SAS programs for determining the number of components using parallel analysis and velicer's MAP test. Behav Res Methods Instrum Comput 2000, 32(3):396-402.
35. Muller MJ, Szegedi A, Wetzel H, Benkert O: Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr Bull 2001, 27(1):19-28.
36. Addington D, Addington J, Maticka-Tyndale E: Specificity of the Calgary depression scale for schizophrenics. Schizophr Res 1994, 11(3):239-244.
37. Miller DD: Atypical antipsychotics: sleep, sedation, and efficacy. Practical Assess Res Eval 2004, 6(Suppl 2):3-7.
38. Teff KL, Kim SF: Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism. Physiol Behav 2011, 104(4):590-598.
39. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Measurement 1977, 1:385-401.
40. Mauritz M, Van Meijel B: Loss and grief in patients with schizophrenia: on living in another world. Arch Psychiatr Nurs 2009, 23(3):251-260.
41. Simonsen C, Sundet K, Vaskinn A, Ueland T, Romm KL, Hellvin T, Melle I, Friis S, Andreassen OA: Psychosocial function in schizophrenia and bipolar disorder: relationship to neurocognition and clinical symptoms. J Int Neuropsychol Soc 2010, 16(5):771-783.
42. Kulhara P, Avasthi A, Chadda R, Chandiramani K, Mattoo SK, Kota SK, Joseph S: Negative and depressive symptoms in schizophrenia. Br J Psychiatry 1989, 154:207-211.
43. Koning JP, Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh B, Van Harten PN, Snieder H, Genetic Risk and Outcome in Psychosis (GROUP) investigators: Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients. Psychopharmacol 2012, 219(3):727-736.